Novartis Profile

USD 0.51  0.59%

Novartis Summary

Novartis AG (NVS) is traded on BATS Exchange in USA. It is located in SWITZERLAND and employs 125,000 people. Novartis AG was previously known as Novartis AG and was traded on OTC Market under the symbol NVSEF. Novartis is listed under Pharmaceutical Products category by Fama And French industry classification.The company currently falls under 'Mega-Cap' category with total capitalization of 194.18 B. Novartis AG runs under Healthcare sector within Drug Manufacturers - Major industry. This company has 2.32 B outstanding shares of which 2.46 M shares are now shorted by investors with about 1.38 days to cover shorted positions. NOVARTIS AG ADS has about 12.96 B in cash with 8.54 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.58.
Check Novartis Probability Of Bankruptcy

Ownership Allocation (%)

Novartis Target Price Odds Analysis

Odds Below 85.46HorizonTargetOdds Above 85.46
89.67%30 days 85.46 10.02%
Based on normal probability distribution, the odds of Novartis to move above current price in 30 days from now is about 10.02% (This Novartis AG probability density function shows the probability of Novartis Stock to fall within a particular range of prices over 30 days) .

Novartis AG Top Holders

Novartis Major Institutional Holders

InstituionSecurity TypeTotal SharesValue
Dodge CoxCommon Shares44.1 M3.3 B
Primecap Management CoCommon Shares22.1 M1.7 B
View Novartis Diagnostics

Novartis AG Income Statement Over Time

Consolidated Income    Earning Before Interest and Taxes EBIT    Net Income    

Novartis Key Fundamentals

Novartis Against Markets

Novartis Current Ratings

Novartis AG 30 Days Performance Scores

Risk Adjusted
Performance Score (0 to 100)
Chance of
Financial Distress (0 to 100%)
Equity ratings for Novartis AG are calculated dynamically based on Macroaxis scoring framework. Click here to learn more
Novartis AG researches, develops, manufactures, and markets a range of healthcare products worldwide. Novartis AG was founded in 1895 and is headquartered in Basel, Switzerland. Novartis operates under Drug Manufacturers - Major classification in USA and traded on BATS Exchange. It employs 125000 people. more
Fama & French Pharmaceutical Products
Pharmaceutical Products
Fama & French Classification
Novartis AG SEC Filings
Novartis SEC Filings
Security & Exchange Commission EDGAR ReportsView All
NameNovartis AG
CEOPaul HudsonView All
Thematic Classifications
Active Investing Ideas
showing 2 out of 3 themes  View All
Analyst Consensus
Piotroski F Score
Macroaxis Advice
Healthcare, Drug Manufacturers - Major
InstrumentUSA Stock View All
Business AddressLichtstrasse 35
Foreign Associate  Argentina
ExchangeBATS Exchange
Prior SymbolNVSEF
IndustryDrug Manufacturers - Major
Phone41 61 324 1111
CurrencyUSD - US Dollar
Next Fiscal Year EndDecember 31, 2019
Most Recent QuarterJune 30, 2018
Last Fiscal Year EndDecember 31, 2017
Date Short InterestAugust 31, 2018

Novartis Directors

Novartis Corporate Directors

Ton Buechner Non-Executive Independent Director
Dimitri Azar Member of the Board of Directors
Frans Houten Non-Executive Independent Director
Please see also Stocks Correlation. Please also try Cryptocurrency Correlation module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins and exchanges.